2011
DOI: 10.1095/biolreprod.110.086850
|View full text |Cite
|
Sign up to set email alerts
|

GATA4 Deficiency Impairs Ovarian Function in Adult Mice1

Abstract: Transcription factor GATA4 is expressed in granulosa cells and, to a lesser extent, in other ovarian cell types. Studies of mutant mice have shown that interactions between GATA4 and its cofactor, ZFPM2 (also termed FOG2), are required for proper development of the fetal ovary. The role of GATA4 in postnatal ovarian function, however, has remained unclear, in part because of prenatal lethality of homozygous mutations in the Gata4 gene in mice. To circumvent this limitation, we studied ovarian function in two g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
36
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 48 publications
(38 citation statements)
references
References 68 publications
1
36
0
Order By: Relevance
“…Recently, Bennett et al (2012) and Kyrönlahti et al (2011) deleted Gata4 in proliferating granulosa cells using Cyp19 - or Amhr2-Cre , respectively (the recombination mediated by these Cre drivers is inefficient within the ovary until after birth) (Bennett et al, 2012; Kyrönlahti et al, 2011). Intriguingly, the Amhr2Cre; Gata4 floxed/floxed adult ovaries had a similar phenotype to the Sf1Cre; Gata4 floxed/floxed ovaries with cyst formation and other reproductive defects such as impaired fertility (Kyrönlahti et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Recently, Bennett et al (2012) and Kyrönlahti et al (2011) deleted Gata4 in proliferating granulosa cells using Cyp19 - or Amhr2-Cre , respectively (the recombination mediated by these Cre drivers is inefficient within the ovary until after birth) (Bennett et al, 2012; Kyrönlahti et al, 2011). Intriguingly, the Amhr2Cre; Gata4 floxed/floxed adult ovaries had a similar phenotype to the Sf1Cre; Gata4 floxed/floxed ovaries with cyst formation and other reproductive defects such as impaired fertility (Kyrönlahti et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…However, all mutant mice had an abnormal response to exogenous gonadotropins and the presence of ovarian cysts was frequently observed (Kyrönlahti et al 2011b, Bennett et al 2012, Efimenko et al 2013. In all cases, mutant females were either sub-fertile or infertile.…”
Section: Gata Proteins In Ovarian Developmentmentioning
confidence: 98%
“…The authors indicated that the activity of Cre recombinase was detected in the Müllerian duct mesenchyme and female gonads as early as E12.5 using the ROSA26 flox-stop-flox lacZ reporter (R26R) mice. Transgenic mouse models in the study of reproduction R7 mice (Kyrönlahti et al 2011b). While ovarian development appeared overtly normal in young animals, the authors noted impaired fertility and cystic ovarian changes in aged females.…”
Section: Gata Proteins In Ovarian Developmentmentioning
confidence: 99%
“…Other promoters such as Anti-Müllerian hormone (Amh), Sf1, inhibinα and steroidogenic acute regulatory protein (Star) also contain the consensus GATA-binding sequence and are activated by GATA4 [7,12] The importance of GATA4 in ovarian development and function has been highlighted recently. Depending upon the type of promoter driving the Cre-Lox recombination system (Amhr2, Cyp19 or Sf1-Cre), the loss of Gata4 expression within the ovary produced either subfertile or infertile animals [8,13,14]. The degree of disruption in follicular development and of formation of ovarian cystic structures varied depending on the Cre recombinase, but regardless of the system used, conditional mutant females showed an aberrant response to exogenous gonadotropins [8,13,14].…”
Section: Introductionmentioning
confidence: 99%
“…Depending upon the type of promoter driving the Cre-Lox recombination system (Amhr2, Cyp19 or Sf1-Cre), the loss of Gata4 expression within the ovary produced either subfertile or infertile animals [8,13,14]. The degree of disruption in follicular development and of formation of ovarian cystic structures varied depending on the Cre recombinase, but regardless of the system used, conditional mutant females showed an aberrant response to exogenous gonadotropins [8,13,14]. The differences found among these transgenic models can be explained by the timing of Cre-recombination (Sf1-Cre is activated embryonically while Cyp19-and Amhr2-Cre act postnatally).…”
Section: Introductionmentioning
confidence: 99%